CAMP4 Therapeutics (CAMP) Revenue & Revenue Breakdown

Overview ForecastOwnership Financials Chart

CAMP4 Therapeutics Revenue Highlights

Latest Revenue (Y)

$186.23M

Latest Revenue (Q)

$795.00K

Main Segment (Y)

Product

Main Geography (Y)

UNITED STATES

CAMP4 Therapeutics Revenue by Period

CAMP4 Therapeutics Revenue by Year

Date	Revenue	Change
2023-11-30	$186.23M	-36.86%
2023-02-28	$294.95M	-0.30%
2022-02-28	$295.84M	-4.13%
2021-02-28	$308.59M	-15.71%
2020-02-29	$366.11M	0.63%
2019-02-28	$363.80M	-0.58%
2018-02-28	$365.91M	4.22%
2017-02-28	$351.10M	25.07%
2016-02-29	$280.72M	12.02%
2015-02-28	$250.61M	6.23%
2014-02-28	$235.90M	30.64%
2013-02-28	$180.58M	30.17%
2012-02-28	$138.73M	21.34%
2011-02-28	$114.33M	1.98%
2010-02-28	$112.11M	13.97%
2009-02-28	$98.37M	-30.19%
2008-03-01	$140.91M	-36.63%
2007-03-03	$222.34M	2.23%
2006-02-28	$217.49M	-1.15%
2005-02-28	$220.03M	71.07%
2004-02-28	$128.62M	28.56%
2003-03-01	$100.04M	-0.67%
2002-02-28	$100.72M	-19.41%
2001-03-03	$124.98M	45.96%
2000-02-26	$85.63M	130.80%
1999-02-27	$37.10M	-20.90%
1998-02-28	$46.90M	-4.87%
1997-03-01	$49.30M	-19.97%
1996-03-02	$61.60M	34.79%
1995-02-28	$45.70M	-

CAMP4 Therapeutics generated $186.23M in revenue during NA 2024, up -36.86% compared to the previous quarter, and up 51.19% compared to the same period a year ago.

CAMP4 Therapeutics Revenue by Quarter

Date	Revenue	Change
2025-09-30	$795.00K	-46.89%
2025-06-30	$1.50M	74.48%
2025-03-31	$858.00K	31.60%
2024-12-31	$652.00K	100.00%
2024-09-30	-	100.00%
2024-06-30	-	100.00%
2024-03-31	-	100.00%
2023-11-30	-	-100.00%
2023-08-31	$350.00K	-99.51%
2023-05-31	$70.89M	-9.70%
2023-02-28	$78.51M	-0.49%
2022-11-30	$78.89M	8.32%
2022-08-31	$72.83M	12.52%
2022-05-31	$64.73M	-5.34%
2022-02-28	$68.38M	-0.58%
2021-11-30	$68.78M	-12.95%
2021-08-31	$79.01M	-0.83%
2021-05-31	$79.67M	-2.77%
2021-02-28	$81.95M	-6.89%
2020-11-30	$88.01M	5.36%
2020-08-31	$83.54M	4.14%
2020-05-31	$80.22M	-8.01%
2020-02-29	$87.20M	-9.72%
2019-11-30	$96.60M	3.60%
2019-08-31	$93.24M	4.68%
2019-05-31	$89.07M	5.56%
2019-02-28	$84.38M	-4.65%
2018-11-30	$88.50M	-7.85%
2018-08-31	$96.04M	1.21%
2018-05-31	$94.89M	0.52%
2018-02-28	$94.39M	9.60%
2017-02-28	$86.13M	3.33%
2016-11-30	$83.35M	-7.88%
2016-08-31	$90.48M	-0.73%
2016-05-31	$91.15M	28.73%
2016-02-29	$70.81M	-5.18%
2015-11-30	$74.67M	6.97%
2015-08-31	$69.81M	6.69%
2015-05-31	$65.43M	-5.44%
2015-02-28	$69.19M	9.43%
2014-11-30	$63.23M	6.78%
2014-08-31	$59.21M	0.39%
2014-05-31	$58.98M	-1.45%
2014-02-28	$59.85M	-5.76%
2013-11-30	$63.50M	7.99%
2013-08-31	$58.81M	9.42%
2013-05-31	$53.75M	11.07%
2013-02-28	$48.39M	9.14%
2012-11-30	$44.34M	0.80%
2012-08-31	$43.99M	0.29%
2012-05-31	$43.86M	16.59%
2012-02-29	$37.62M	14.87%
2011-11-30	$32.75M	-3.10%
2011-08-31	$33.80M	-2.18%
2011-05-31	$34.55M	19.38%
2011-02-28	$28.94M	-2.06%
2010-11-30	$29.55M	0.21%
2010-08-31	$29.49M	11.93%
2010-05-31	$26.35M	-23.59%
2010-02-28	$34.48M	12.35%
2009-11-30	$30.69M	28.20%
2009-08-31	$23.94M	4.09%
2009-05-31	$23.00M	7.84%
2009-02-28	$21.33M	-17.45%
2008-11-30	$25.83M	10.84%
2008-08-31	$23.31M	-16.46%
2008-05-31	$27.90M	-6.33%
2008-02-28	$29.79M	-

CAMP4 Therapeutics generated $795.00K in revenue during Q3 2025, up -46.89% compared to the previous quarter, and up Infinity% compared to the same period a year ago.

CAMP4 Therapeutics Revenue Breakdown

CAMP4 Therapeutics Revenue Breakdown by Product

Annual Revenue by Product

Product/Service	Feb 23	Feb 22	Feb 21	Feb 20	Feb 19
Application Subscriptions And Other Services	$106.07M	$112.92M	$115.10M	-	-
Product	$188.88M	$182.92M	$193.49M	$285.88M	-
Application Subscriptions And Related Products And Other Services	-	-	-	$124.89M	$77.92M
Telematics Products	-	-	-	$241.21M	-

CAMP4 Therapeutics's latest annual revenue breakdown by segment (product or service), as of Feb 23: Product (64.04%), and Application Subscriptions And Other Services (35.96%).

Quarterly Revenue by Product

Product/Service	Nov 23	Aug 23	May 23	Feb 23	Nov 22	Aug 22	May 22	Feb 22	Nov 21	Aug 21	May 21	Feb 21	Nov 20	Aug 20	May 20	Feb 20	Nov 19	Aug 19	May 19	Feb 19
Application Subscriptions And Other Services	$22.42M	$24.39M	$24.59M	$28.05M	$25.56M	$27.13M	$25.33M	$29.36M	$28.40M	$27.48M	$27.68M	$25.71M	$29.68M	$32.59M	$27.11M	-	-	-	-	-
Product	$31.20M	$37.33M	$46.30M	$50.46M	$53.33M	$45.69M	$39.40M	$39.01M	$40.38M	$51.53M	$52.00M	$31.11M	$58.33M	$50.94M	$53.11M	$63.19M	$62.03M	$63.56M	$64.42M	-
Software And Subscription Services	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$34.77M	-	-	-	-
Telematics Systems	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$52.43M	-	-	-	-
Application Subscriptions And Related Products And Service	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$33.41M	$31.20M	$25.51M	-
Application Subscriptions And Related Products And Other Services	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$19.96M

CAMP4 Therapeutics's latest quarterly revenue breakdown by segment (product or service), as of Nov 23: Product (58.19%), and Application Subscriptions And Other Services (41.81%).

CAMP4 Therapeutics Revenue Breakdown by Country

Annual Revenue by Country

Country	Feb 23	Feb 22	Feb 21	Feb 20	Feb 19
UNITED STATES	$185.47M	$197.18M	$200.66M	$266.41M	$268.45M
Latin America	$32.01M	-	-	-	-
EMEA	$54.70M	-	-	-	-
All Other	$4.33M	$3.10M	$10.06M	$14.11M	$6.94M
Asia Pacific	$18.45M	$19.03M	$12.28M	$9.17M	$13.96M
L A S F	-	$24.76M	-	-	-
E M E A	-	$51.77M	$58.47M	$55.19M	$49.50M
South America	-	-	$27.11M	$21.23M	$15.13M
CANADA	-	-	-	-	$9.81M

CAMP4 Therapeutics's latest annual revenue breakdown by geography, as of Feb 23: UNITED STATES (62.88%), EMEA (18.54%), Latin America (10.85%), Asia Pacific (6.26%), and All Other (1.47%).

Quarterly Revenue by Country

Country	Nov 23	Aug 23	May 23	Feb 23	Nov 22	Aug 22	May 22	Feb 22	Nov 21	Aug 21	May 21	Feb 21	Nov 20	Aug 20	May 20	Feb 20	Nov 19	Aug 19	May 19	Feb 19
EMEA	$14.22M	$13.85M	$14.96M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Latin America	$3.87M	$5.25M	$7.10M	$8.83M	$9.01M	$8.19M	$5.98M	$1.04M	$4.23M	$3.49M	-	-	-	-	-	-	-	-	-	-
UNITED STATES	$29.20M	$32.59M	$39.40M	$48.44M	$50.39M	$46.24M	$40.40M	$47.05M	$51.20M	$29.35M	$60.82M	$58.95M	$51.55M	$64.73M	$69.96M	$68.68M	$63.12M	$60.30M	-	-
All Other	$1.51M	$2.39M	$1.23M	$1.43M	$1.78M	$534.00K	$589.00K	$444.00K	$770.00K	$1.39M	$2.07M	$1.98M	$2.04M	$1.66M	$4.38M	$-2.24M	$5.49M	$2.61M	$3.79M	$-4.25M
Asia Pacific	$4.82M	$7.64M	$6.16M	$4.85M	$2.79M	$5.59M	$5.22M	$3.49M	$5.76M	$2.79M	$5.40M	$4.20M	$4.03M	$1.70M	$2.34M	$1.77M	$3.04M	$1.94M	$2.41M	$3.25M
E M E A	-	-	$17.00M	$14.92M	$12.28M	$12.54M	$12.32M	$12.10M	$12.88M	$14.47M	$13.26M	$13.77M	$15.54M	$15.91M	$13.56M	$14.82M	$13.30M	$13.43M	$12.04M	-
L A S F	-	-	-	-	-	-	-	$5.07M	$5.54M	-	-	-	-	-	-	-	-	-	-	-
U S	-	-	-	-	-	-	-	-	$44.61M	$54.32M	-	-	-	-	-	-	-	-	-	-
South America	-	-	-	-	-	-	-	-	-	$7.63M	$6.53M	$8.03M	$7.35M	$5.69M	$6.04M	$10.17M	-	-	-	-
CANADA	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$2.24M	$2.48M	$2.84M	$2.86M

CAMP4 Therapeutics's latest quarterly revenue breakdown by geography, as of Nov 23: UNITED STATES (54.45%), EMEA (26.52%), Asia Pacific (8.99%), Latin America (7.21%), and All Other (2.82%).

CAMP4 Therapeutics Peer Comparison by Revenue

Ticker	Company	Last Year Revenue	Last Quarter Revenue
CAMP	CAMP4 Therapeutics	$186.23M	$795.00K
VXRT	Vaxart	$28.70M	$39.73M
HYFT	MindWalk	$24.52M	$6.98M
ATYR	aTyr Pharma	$353.00K	$190.00K
ALXO	ALX Oncology	-	-
RPTX	Repare Therapeutics	-	-
QNCX	Quince Therapeutics	-	-
UNCY	Unicycive Therapeutics	-	-
BMEA	Biomea Fusion	-	-
ACRV	Acrivon Therapeutics	-	-
PMVP	PMV Pharmaceuticals	-	-

CAMP Revenue FAQ

What is CAMP4 Therapeutics’s yearly revenue?

CAMP4 Therapeutics's yearly revenue for 2024 was $186.23M, representing a decrease of -36.86% compared to 2023. The company's yearly revenue for 2023 was $294.95M, representing a decrease of -0.30% compared to 2022. CAMP's yearly revenue for 2022 was $295.84M, representing a decrease of -4.13% compared to 2021.

What is CAMP4 Therapeutics’s quarterly revenue?

CAMP4 Therapeutics's quarterly revenue for Q3 2025 was $795K, a -46.89% decrease from the previous quarter (Q2 2025), and a 0% increase year-over-year (Q3 2024). The company's quarterly revenue for Q2 2025 was $1.5M, a 74.48% increase from the previous quarter (Q1 2025), and a 0% increase year-over-year (Q2 2024). CAMP's quarterly revenue for Q1 2025 was $858K, a 31.60% increase from the previous quarter (Q4 2024), and a 0% increase year-over-year (Q1 2024).

What is CAMP4 Therapeutics’s revenue growth rate?

CAMP4 Therapeutics's revenue growth rate for the last 3 years (2022-2024) was -37.05%, and for the last 5 years (2020-2024) was -49.13%.

What are CAMP4 Therapeutics’s revenue streams?

CAMP4 Therapeutics's revenue streams in b 23 are Application Subscriptions And Other Services, and Product. Application Subscriptions And Other Services generated $106.07M in revenue, accounting 35.96% of the company's total revenue, down -6.07% year-over-year. Product generated $188.88M in revenue, accounting 64.04% of the company's total revenue, up 3.26% year-over-year.

What is CAMP4 Therapeutics’s main source of revenue?

For the fiscal year ending Feb 23, the largest source of revenue of CAMP4 Therapeutics was Product. This segment made a revenue of $188.88M, representing 64.04% of the company's total revenue.